MedTrace Logo

Leaders Free Japan

NCT02348021 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2015-09-29

No results posted yet for this study

Summary

Prospective, multi-center, non-randomized, open-label trial designed to enroll 139 patients in Japan. All patients will receive a DCS and will be followed for 2 years.

Conditions

  • Coronary Disease

Interventions

PROCEDURE

Percutaneous coronary intervention (PCI)

DRUG

Dual Anti Platelet Therapy

All patients will receive Dual Anti Platelet Therapy for one month

Sponsors & Collaborators

  • Biosensors Japan Co. Ltd.

    collaborator UNKNOWN

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Shigeru Saito, MD · Shonan Kamakura General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-04-30
Completion
2017-07-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02348021 on ClinicalTrials.gov